<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Guidance for Industry on Oversight of Clinical Investigations-A Risk-Based Approach to Monitoring; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Guidance for Industry on Oversight of Clinical Investigations-A Risk-Based Approach to Monitoring; Availability</h1>
    <p class="timestamp">Published: 2013-08-07 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Oversight of Clinical Investigations--A Risk-Based Approach to Monitoring." This guidance assists sponsors in developing risk-based monitoring strategies and plans for clinical investigations of human drugs, biologics, medical devices, and combinations thereof. The overarching goal of this guidance is to enhance human subject protection and the quality of clinical trial data by focusing spo...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-19004</p>
    <p><strong>Publication Date:</strong> 2013-08-07</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/08/07/2013-19004/guidance-for-industry-on-oversight-of-clinical-investigations-a-risk-based-approach-to-monitoring">https://www.federalregister.gov/documents/2013/08/07/2013-19004/guidance-for-industry-on-oversight-of-clinical-investigations-a-risk-based-approach-to-monitoring</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-19004</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
